latentbrief
← Back to editorials

Editorial · Policy & Regulation

AI in Medicare Prior Authorization: A Step Too Far

2h ago3 min brief

The introduction of artificial intelligence (AI) into Medicare's prior authorization process through the Wasteful and Inappropriate Service Reduction (WISeR) pilot program raises significant concerns about patient care and access to necessary treatments. While the goal of reducing waste and fraud in healthcare spending is commendable, the reliance on AI for determining medical necessity introduces potential risks that could harm vulnerable patients.

The WISeR program, launched in January 2024, affects six states-New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington-and targets over a dozen medical procedures, including epidural steroid injections and nerve-stimulation therapies. However, early reports indicate that the AI-driven system is causing delays of up to three weeks for prior authorization decisions, compared to the previous 24 to 72-hour turnaround time. This delay forces patients to reschedule treatments multiple times, allowing their conditions to worsen and increasing unnecessary suffering.

Moreover, the lack of transparency in AI decision-making further exacerbates these issues. Patients and healthcare providers are left in the dark when denials occur, often without a clear explanation from human reviewers. U.S. Senator Maria Cantwell has called for immediate action, urging CMS to ensure that all denials include written explanations from humans rather than relying solely on AI-generated decisions. The absence of such transparency undermines trust between patients and their medical teams, who are already strained by the complexities of healthcare delivery.

Critics argue that the WISeR program's structure incentivizes third-party contractors to maximize profitability by denying claims, rather than focusing on patient outcomes. This profit motive creates a conflict of interest, as companies stand to gain financially from reducing payouts. Iris Smith, an 80-year-old Medicare beneficiary in Florida, expresses concern that AI could become a barrier between patients and the care they need. "My doctors know me," she says. "When I'm in pain, I need something to take care of it." The human element is irreplaceable in healthcare, and replacing it with an algorithm risks overlooking individual circumstances that require personalized attention.

Looking forward, the future of AI in Medicare must balance efficiency with patient-centered care. While AI has potential applications in streamlining administrative tasks and detecting fraud, its role in making decisions about medical necessity should be carefully scrutinized. Policymakers must ensure that any expansion of AI-driven prior authorization is accompanied by robust safeguards to protect patients' access to necessary treatments.

In conclusion, the WISeR program's reliance on AI for prior authorization represents a step too far in the pursuit of cost savings. The delays, lack of transparency, and potential profit motive create significant risks for patient care. Moving forward, CMS must prioritize patient outcomes over cost-cutting measures, ensuring that healthcare decisions remain in the hands of trained medical professionals rather than algorithms.

Editorial perspective - synthesised analysis, not factual reporting.

Terms in this editorial

prior authorization
A process where insurance companies review medical treatments to decide if they're necessary and should be covered. It's meant to prevent waste and fraud but can slow down patient care if not managed well.
Wasteful and Inappropriate Service Reduction (WISeR)
A Medicare pilot program using AI to reduce healthcare spending by identifying unnecessary treatments. Critics worry it may delay care and harm patients.

If you liked this

More editorials.